InvestorsHub Logo
Followers 4
Posts 579
Boards Moderated 0
Alias Born 04/14/2001

Re: Patricia_1 post# 121

Wednesday, 03/10/2004 1:31:52 PM

Wednesday, March 10, 2004 1:31:52 PM

Post# of 141
Jerry Newman interviewed Jan 20, 2004 on ceocast.

I do not remember anyone posting before.

www.ceocast.com

http://www.ceocast.com

Interesting interview.

G$

http://ragingbull.lycos.com/mboard/boards.cgi?board=EXTI&read=24589

From CEOCAST interview...Xenotech has over 100 leads in possible sale of the cells made by EXTI.

Listen for yourselves.

G$

http://ragingbull.lycos.com/mboard/boards.cgi?board=EXTI&read=24590

By: gheyer
10 Mar 2004, 12:21 PM EST
Msg. 24591 of 24606
Jump to msg. #
From interview - "what should investors look forward to"

Newman said they should look forward to sales agreements with major pharmaceutical companies that show acceptance in the industry"

Listen for yourselves. Interview dated Jan 20, 2004.


http://ragingbull.lycos.com/mboard/boards.cgi?board=EXTI&read=24591

Interview site

http://www.ceocast.com/index.cfm

By: rim127
10 Mar 2004, 12:37 PM EST
Msg. 24597 of 24606
(This msg. is a reply to 24594 by dcjansi.)
Jump to msg. #
You have to turn off your popup blocker to get the CEOCAST to work. Then you have to register and then run the newscast.

http://ragingbull.lycos.com/mboard/boards.cgi?board=EXTI&read=24597

By: rim127
10 Mar 2004, 12:53 PM EST
Msg. 24599 of 24607
(This msg. is a reply to 24589 by gheyer.)
Jump to msg. #
CEOCAST also mentions...
- Exten hopes to test the liver assit device to see if it performs liver dialysis. They hope to joint venture with another company in that business if they are successful.
- Exten hopes that adult stem cells will be used to treat liver disease in five or more years from now.

http://ragingbull.lycos.com/mboard/boards.cgi?board=EXTI&read=24599




Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.